When an outbreak of febrile haemorrhagic disease fi rst occurred in the Ulge Province of Angola in November, 2004, it was the poliomyelitis surveillance offi cer in that province who did the initial case investigation, collected blood specimens, and ensured that those specimens were sent to a WHO Collaborating Centre for Haemorrhagic Fevers. 1 After the diagnosis of Marburg haemorrhagic fever, the poliomyelitis surveillance offi cers provided logistic support to the national and international team that implemented containment activities, which included case fi nding, contact tracing, case management and infection control in adapted isolation facilities, on-site laboratory diagnosis, safe burial, and social mobilisation. In addition, all 65 poliomyelitis eradication offi cers in Angola, of whom six are international and the rest nationals, organised mobile teams for active surveillance in provinces at risk outside the outbreak zone to investigate and report suspect cases.
These poliomyelitis surveillance offi cers are part of a worldwide system for surveillance of acute fl accid paralysis that identifi es, investigates, and collects speci mens each year from over 60 000 paralysed children under the age of 15 years in more than 190 countries. 2 The system is supported by the poliomyelitis eradication partners-Rotary International, UNICEF, the Centers for Disease Control and Prevention, and WHO-through the Global Polio Eradication Initiative (GPEI). This system, which is constantly monitored for performance against international surveillance standards, provides a structure for rapidly detecting and responding to diseases of national and international importance, and in some resource-poor countries in Africa and south Asia is the most reliable surveillance and response mechanism available.
Poliomyelitis surveillance offi cers also support countries in planning, social mobilisation, and implementation of poliovirus vaccination campaigns; and they train school teachers and community volunteers to participate in vaccination campaigns along with health workers. Vaccination coverage of more than 90% is usually attained, providing near-universal access to oral poliovirus vaccine, with performance assessed by independent monitors.
Poliomyelitis eradication and pandemic infl uenza
Surveillance for acute fl accid paralysis is underpinned by a network of 145 laboratories in 90 countries that isolate and genetically characterise polioviruses, providing an understanding of their geographical distribution and guiding response activities. 3 These laboratories, some of which receive external fi nancial support from GPEI, use standard equipment, reagents, and methods. They must be reaccredited every 1-2 years to remain in the network, and are distributed around the world (fi gure).
There are 279 international and 2964 national GPEI-funded poliomyelitis eradication staff in over 50 countries with or at risk of wild poliovirus infection (table) . These staff are concentrated in areas with the weakest health systems. Mainly because of fi nancing constraints, the number of GPEI-funded surveillance offi cers is systematically reduced as countries are certifi ed poliomyelitis-free, with some transferred to other international funding sources (eg, for activities to reduce measles mortality) or national government service. Poliomyelitis surveillance offi cers are usually medical epidemiologists who have been specially trained in poliomyelitis surveillance, case investigation and outbreak response, and are equipped with computers, transport, and real-time communication capacity through cell or satellite phones.
In over 125 countries, the epidemiological and laboratory capacities have been broadened to include diseases such as measles, yellow fever, the haemorrhagic fevers, meningitis, and Japanese encephalitis. 4 The network has also been mobilised to support countries during the outbreak of severe acute respiratory syndrome. Most recently, capacities have been broadened to include avian infl uenza. For example, in Kaduna State in Nigeria, poliomyelitis surveillance offi cers provided key messages about avian infl uenza to community leaders during poliomyelitis vaccination campaigns in early February, and poliomyelitis surveillance offi cers are now providing such messages throughout Nigeria. Poliomyelitis surveillance offi cers in Maharashtra State in India have been asked to report any information they obtain on sick or dying poultry to federal health authorities.
Further broadening the epidemiological capacities of poliomyelitis surveillance offi cers by providing training in infl uenza can substantially enhance surveillance and investigation of severe respiratory disease in human beings living in areas where there are lethal outbreaks in poultry and, potentially, assist in the early detection of avian disease. Broadening the laboratory capacity to include diagnosis of H5N1 where feasible could provide Specialised reference laboratory (7)
Regional reference laboratory ( wider support to the infl uenza-laboratory network. Should there be a need for rapid and eff ective social mobilisation and distribution of antiviral drugs or eventually vaccines, the capacity of the poliomyelitis eradication offi cers to ensure access is proven.
External support for national poliomyelitis surveillance is presently borne entirely by GPEI, with about US$100 million in annual funding from donor countries, multilateral institutions, foundations, and Rotary International. Broadening the funding base for this unique international public-health surveillance and laboratory network could maintain its geographical distribution and ensure a stronger response capacity for any national or international pandemic of infl uenza. To ignore this dividend of the 20-year international investment in poliomyelitis eradication will increase vulnerability to avian infl uenza in countries where health systems are weakest and least able to detect and respond. The widespread establishment of immunisation programmes over the past 30 years has provided remarkable achievements. Smallpox was eradicated, the worldwide incidence of poliomyelitis has dropped 99% since 1988, 1 and more than 2 million children's deaths from diphtheria, tetanus, pertussis, and measles are prevented each year (fi gure). 2,3 Hepatitis B vaccination could annually prevent an additional 600 000 future deaths (from liver cirrhosis and hepatoma). 4 More than 75% of children younger than 1 year of age receive three doses of diphtheria, tetanus, and pertussis, and at least one dose of measles vaccine. 5 Despite such success, serious challenges remain. In 2002, an estimated 1·4 million children-13% of the 10·5 million children who die each year (2000-03) 6 -died of diseases preventable with widely available vaccines for pertussis, measles, tetanus, Haemophilus infl uenzae type b, poliomyelitis, diphtheria, and yellow fever. 7 More eff orts are needed to immunise the un-immunised and save lives.
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Immunisation can substantially contribute to achieving the Millennium Development Goals, 8 especially Goal 4, which calls for a reduction by two-thirds of under-5 mortality by 2015. 8 Improving services to deliver traditional vaccines will reduce the 13% of child deaths mentioned above. Introducing new vaccines will help to prevent some of the 1·1 million (10%) child deaths attributed to pneumococcal disease, meningococcal disease, and rotavirus. 7 In 72 of the world's poorest countries-those with income per head of less than US$1000-reaching more children and introducing new vaccines will require more resources, as immunisation costs rise from $2·5 billion a year in 2005 to more than $4 billion a year by 2015. More than 40 million deaths can be prevented over the next decade, at a cost of under $1000 a life saved.
Against this background, WHO and UNICEF are joining forces, and have developed the Global Immunization Vision and Strategy 2006-2015 (GIVS). 9 Both the World Health Assembly, 10 and UNICEF's Executive Board 11 recently welcomed the GIVS document as the framework for strengthening national immunisation programmes in the next decade. GIVS outlines four major strategic areas; we discuss each in turn.
